Yesterday GSK announced the forthcoming launch of CancerTrialsApp – touted as “the first free geolocating cancer clinical trials application” for the iPhone and iPad. Last week Pfizer also announced they are developing an app that allows easy communication between the company and healthcare professionals. So how might these examples encourage cautious and/or unconvinced pharma execs of the value of apps?
